ROLE OF DIET AND EVALUATION OF THE EFFECT OF TAGARA CHURNA AND SANKHAPUSPI CHURNA INANXIETY DISORDERS

Phase 2

• Conditions: Health Condition 1: F411- Generalized anxiety disorder

• Registration Number: CTRI/2021/07/034582
• Lead Sponsor: ational Institute of Ayurveda Jaipur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) The patients with sign and symptoms of Chittaodvega

(Anxiety disorders) such as Chinta, Soka, Bhaya, Krodha,

Moha, Bhrama, Vishada, Pralapa, Aswapna/Alpanidra,

Anavasthitachitatva, Durnama, Alasya, Tandra,

Vyahitindriyatvam.

2) Patient who comes under Hamiltonâ??s Anxiety tools such as

anxious mood, tension, fear, insomnia, intellectual, depressed

mood, physical/muscular pain, senses, cardiovascular

symptoms, respiratory symptoms, digestive symptoms,

genitourinary symptoms, autonomic symptoms, behavior at

interview.

3) Patient who comes under Hamiltonâ??s Anxiety score

between 18 to 24

Exclusion Criteria

1) Patient below the age 18 yrs and above 70 yrs.

2) Severely malnourished and debilitated patients.

3) The patient suffering from any critical mental illness

like Schizophrenia, Parkinsonism, Alzheimer,

Encephalopathy, pregnant women and Epilepsy.

4) Patients suffering from any chronic disorders or taking

any long term medications.

5) Patients associated with any other serious systemic

disease or complications.

6) Patients suffering from malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) To observe the role of dietary factors leading to <br/ ><br>Chittaodvega (anxiety disorders) by survey of 300 <br/ ><br>patients. <br/ ><br>2) To observe statistically significant changes in Hamiltonâ??s <br/ ><br>Anxiety Rating Scale (HamA) before and after <br/ ><br>intervention i.e. between day 0 and day 30.Timepoint: 30 DAYS

Secondary Outcome Measures

Name	Time	Method
1) To observe the improvement in the sign and symptoms of <br/ ><br>the enrolled patients. <br/ ><br>2) To observe the improvement in the quality of life in the <br/ ><br>enrolled patients .Timepoint: 30 DAYS